BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8658639)

  • 21. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thirty-two years of renal transplantation in Zurich.
    Candinas D; Schlumpf R; Röthlin MA; Binswanger U; Largiadèr F
    Clin Transpl; 1996; ():241-7. PubMed ID: 9286573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living donor renal transplantation: prognostic factors on graft survival.
    Cacho DT; Piqué AA; Cusi LI; Reyes LI; Salinas FO; del Pozo RG
    Transplant Proc; 2005 Nov; 37(9):3679-81. PubMed ID: 16386503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of some immunological and non-immunological factors on early and distant function of transplanted kidney].
    Sierńko J
    Ann Acad Med Stetin; 2004; 50(1):53-67. PubMed ID: 16871744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
    El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA
    Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of tissue typing for kidney transplantation in the Middle East.
    Opelz G
    Transplant Proc; 1993 Jun; 25(3):2237-8. PubMed ID: 8516884
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of HLA class I antigen matching and early graft outcome in living donor kidney transplantation.
    Iqbal MM; Hossain RM; Rashid HU; Rahman MH; Datta M; Hassan MS
    Transplant Proc; 2006 Sep; 38(7):2012-3. PubMed ID: 16979982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spousal and other living renal donor transplants.
    Terasaki PI; Cecka JM; Gjertson DW; Cho YW
    Clin Transpl; 1997; ():269-84. PubMed ID: 9919411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of time of rejection on long-term graft survival in renal transplantation.
    Opelz G; Döhler B;
    Transplantation; 2008 Mar; 85(5):661-6. PubMed ID: 18337655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of amino acid residue matching for HLA molecule in graft survival in renal transplantation.
    Ogahara S; Naito S; Noda R; Michinaga I; Murata T
    Transplant Proc; 1996 Jun; 28(3):1260-1. PubMed ID: 8658650
    [No Abstract]   [Full Text] [Related]  

  • 34. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of donor and recipient age on the outcome of kidney transplantation.
    Kwon OJ; Lee HG; Kwak JY
    Transplant Proc; 2004 Sep; 36(7):2043-5. PubMed ID: 15518739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of donor age on outcome of living related kidney transplantation.
    Kim YL; Kim JH; Kwon TH; Cho DK; Kim YW; Chang SI; Chung SK; Chang SK
    Transplant Proc; 1996 Jun; 28(3):1580-1. PubMed ID: 8658793
    [No Abstract]   [Full Text] [Related]  

  • 38. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Significance of mixed lymphocyte culture (MLC) in renal transplants from living donors].
    Zanuso C; Pontiero P; Ancona G; Galvani E; Confortini P
    Minerva Chir; 1980 May; 35(10):791-2. PubMed ID: 6450337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One thousand years of continuous function in 49 renal transplant recipients: clinical, renal, and immunologic features of 20-year successes.
    Braun WE; Popowniak KL; Gifford RW; Nakamoto S; Straffon RA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1331-3. PubMed ID: 8442132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.